Summary

The primary role of the EHS intern is to support EHS compliance activities related to the Gene Therapy Manufacturing Facility located in Bedford, MA and Quality Control Labs located in Woburn, MA. This includes supporting EHS functions within manufacturing, facilities, engineering, warehouse, laboratories, and office spaces. This role will support site inspections, data management, metric reporting, and continuous improvement projects. In addition, this assignment will offer the opportunity to learn about gene therapy manufacturing and hands-on experience supporting manufacturing process systems in a GMP environment and Quality Control laboratories.

Job description

Position Summary

The primary role of the EHS intern is to support EHS compliance activities related to the Gene Therapy Manufacturing Facility located in Bedford, MA and Quality Control Labs located in Woburn, MA. This includes supporting EHS functions within manufacturing, facilities, engineering, warehouse, laboratories, and office spaces. This role will support site inspections, data management, metric reporting, and continuous improvement projects. In addition, this assignment will offer the opportunity to learn about gene therapy manufacturing and hands-on experience supporting manufacturing process systems in a GMP environment and Quality Control laboratories.

Responsibilities

Draft, deliver and support EHS department communications (safety alerts, events, training).
Assist with EHS Insight data management including incident investigations, hazard reporting, inspections, corrective actions, and compliance tasks.
Assist in coordination and execution of Emergency Response activities (evacuation, medical, spill response, business continuity).
Assist with contractor management oversight, including developing Job Hazard Analysis and safe work permits.
Collaborate with key stakeholders (Facilities, Quality Control) regarding inspection findings and corrective action planning.
Support a fast-paced work environment with many tasks and shifting priorities.

Requirements

BS/BA in technical discipline: Safety, Environmental, Life Sciences, Engineering or similar field.
0-1 year experience in the EHS field, prior internship is desired.
Strong communication and organization skills.
Creative problem-solving capabilities.

Physical Demands/Work Environment/Safety Considerations

Stand for extended periods of time with periodic stooping / bending / kneeling
Able to lift, push, pull up to 50lbs.
Climb ladders and stairs of various heights.
Work in a controlled environment requiring GxP gowning and wear protective clothing over the head, face, hands, feet, and body. This requires the ability to change clothes into appropriate gowning and personal protective equipment.
Certain tasks may require the use of a respirator; medical clearance will be required in advance.
Must remove all make-up, jewelry, and contact lenses while in the manufacturing environment.
Working in temperature-controlled environments (cold rooms)

Requirements

BS/BA in technical discipline: Safety, Environmental, Life Sciences, Engineering or similar field
0-1 year experience in the EHS field, prior internship is desired
Strong communication and organization skills
Creative problem-solving capabilities

Benefits

Generous vacation time
Public holidays
Volunteer days
Long-term incentive plans
Employee stock purchase plan
Employee wellbeing benefits
Fitness reimbursement
Tuition sponsorship
Professional development plans
Annual bonus
Equity incentives

Company overview

Ultragenyx Pharmaceutical Inc. is a pioneering biopharmaceutical company dedicated to developing and commercializing novel therapies for serious rare and ultra-rare genetic diseases. Founded in 2010 by Dr. Emil D. Kakkis, the company is headquartered in Novato, California and operates globally with a presence in North America, Europe, Asia, and Latin America. Ultragenyx has built a diverse portfolio of approved medicines including Crysvita® for X-linked hypophosphatemia, Mepsevii® for mucopolysaccharidosis type VII, Dojolvi® for long-chain fatty acid oxidation disorders, and Evkeeza® for homozygous familial hypercholesterolemia. The company employs multiple therapeutic modalities including biologics, small molecules, gene therapies, and antisense oligonucleotides to address diseases with high unmet medical needs. With over 1,000 employees and a robust clinical pipeline, Ultragenyx maintains one of the most extensive rare disease development programs in the industry, focusing on metabolic disorders, bone diseases, enzyme deficiencies, and neurological conditions. The company is publicly traded on NASDAQ under the symbol RARE and continues to advance its mission of delivering transformative treatments to patients with limited or no therapeutic options.